ダウンロード数: 387

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
eji.201545616.pdf108.6 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorTakeuchi, Osamuen
dc.contributor.alternative竹内, 理ja
dc.date.accessioned2015-11-10T02:27:44Z-
dc.date.available2015-11-10T02:27:44Z-
dc.date.issued2015-05-07-
dc.identifier.issn0014-2980-
dc.identifier.urihttp://hdl.handle.net/2433/201501-
dc.description.abstractThe expression of interferon (IFN) β is highly induced in immune and nonimmune cells in response to virus infection. This upregulation is mediated at both transcriptional and posttranscriptional levels. Whereas the signaling pathways triggered by innate virus receptors leading to transcription factor activation have been extensively studied, the mechanisms by which IFN-β mRNA stability is posttranscriptionally controlled are not fully understood. In this issue of the European Journal of Immunology, Herdy et al. [Eur. J. Immunol. 2015 45:1500-1511] show that a human RNA-binding protein, embryonic lethal, abnormal vision, drosophila-like 1 (ELAVL1)/Hu antigen R (HuR), strongly associates with IFN-β mRNA via AU-rich sequences present in its 3' untranslated region in various human cell lines. The authors show that ELAVL1/HuR is required for the stabilization of IFN-β mRNA, and suppression of ELAVL1/HuR by its inhibitor MS-444 leads to impaired expression of IFN-β in response to viral dsRNA treatment. Thus, this study uncovers a novel mechanism of posttranscriptional IFN-β mRNA regulation in response to virus infection, through IFN-β stabilization by ELAVL1/HuR. Future studies are expected to identify further regulatory mechanisms of IFN-β stabilization and destabilization in the course of antiviral responses.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherwileyen
dc.rightsThis is the peer reviewed version of the following article: Takeuchi, O. (2015), HuR keeps interferon-β mRNA stable. Eur. J. Immunol., 45: 1296–1299, which has been published in final form at http://dx.doi.org/10.1002/eji.201545616. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.en
dc.rightsThe full-text file will be made open to the public on 7 May 2016 in accordance with publisher's 'Terms and Conditions for Self-Archiving'.en
dc.rightsThis is not the published version. Please cite only the published version.en
dc.rightsこの論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。ja
dc.subjectAntiviral responseen
dc.subjectELAVL1/HuRen
dc.subjectGene regulationen
dc.subjectinnate immunityen
dc.subjectmRNA stabilityen
dc.subjectMass spectrometryen
dc.subjectType I interferonen
dc.subject.meshHu Paraneoplastic Encephalomyelitis Antigens/immunologyen
dc.subject.meshHumansen
dc.subject.meshInterferon Type I/biosynthesisen
dc.subject.meshInterferon-beta/geneticsen
dc.titleHuR keeps interferon-β mRNA stable.en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.ncidAA00639610-
dc.identifier.jtitleEuropean journal of immunologyen
dc.identifier.volume45-
dc.identifier.issue5-
dc.identifier.spage1296-
dc.identifier.epage1299-
dc.relation.doi10.1002/eji.201545616-
dc.textversionauthor-
dc.startdate.bitstreamsavailable2016-05-07-
dc.identifier.pmid25824620-
dcterms.accessRightsopen access-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。